| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 45.226 | 55.736 | 53.341 | 51.807 | 53.048 | 47.245 | 48.646 | 51.437 | 71.921 | 80.313 |
| Total Income - EUR | 45.315 | 55.754 | 56.179 | 51.847 | 53.108 | 47.324 | 48.647 | 52.322 | 71.922 | 80.332 |
| Total Expenses - EUR | 29.150 | 35.468 | 35.961 | 34.512 | 36.296 | 31.572 | 28.773 | 31.130 | 37.903 | 46.225 |
| Gross Profit/Loss - EUR | 16.166 | 20.286 | 20.218 | 17.335 | 16.813 | 15.752 | 19.874 | 21.193 | 34.019 | 34.107 |
| Net Profit/Loss - EUR | 14.806 | 19.728 | 19.656 | 16.816 | 16.284 | 15.305 | 19.446 | 20.680 | 33.544 | 31.986 |
| Employees | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Phimed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.999 | 1.659 | 2.256 | 1.670 | 1.607 | 4.025 | 2.622 | 1.973 | 1.261 | 3.896 |
| Current Assets | 82.394 | 22.235 | 39.610 | 53.122 | 63.892 | 39.656 | 54.447 | 21.493 | 38.199 | 50.127 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 222 | 217 | 218 | 217 | 216 |
| Receivables | 50.615 | 11.800 | 13.168 | 12.567 | 12.674 | 7.544 | 7.721 | 8.339 | 10.773 | 9.383 |
| Cash | 31.779 | 10.435 | 26.442 | 40.555 | 51.218 | 31.890 | 46.509 | 12.936 | 27.208 | 40.528 |
| Shareholders Funds | 81.291 | 19.782 | 35.294 | 51.463 | 61.870 | 41.183 | 54.455 | 21.796 | 36.481 | 50.782 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.102 | 4.112 | 6.573 | 3.329 | 3.630 | 2.499 | 2.613 | 1.670 | 2.979 | 3.240 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Phimed Srl